Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 377 transactions totaling $33.4M, demonstrating a bearish sentiment with -$27.6M in net insider flow. The most recent transaction on Dec 8, 2025 involved a sale of 8,820 shares valued at $402.1K.
XENE Insider Activity Summary
Who Is Buying XENE Stock?
No significant insider buying has been recorded for XENE in the recent period.
Who Is Selling XENE Stock?
No significant insider selling has been recorded for XENE in the recent period.
Is Xenon Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for XENE is bearish with an Insider Alignment Score of 9/100 and a net flow of -$27.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
XENE Frequently Asked Questions
Understanding XENE Insider Activity
Insider trading at Xenon Pharmaceuticals Inc. (XENE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading XENE stock, having executed 377 transactions in the past 90 days. The most active insider is Simon N. Pimstone (Executive), who has made 72 transactions totaling $20.5M.
Related Tools
Track Xenon Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at XENE file new Form 4 transactions